Brazil is a major donor to Gavi and an increasingly influential actor in global health. Through its leadership in health diplomacy, South-South cooperation and vaccine manufacturing, Brazil has consistently promoted equitable access to medicines and vaccines at the domestic, regional and international levels.
Brazil became the first Latin American donor to Gavi through a US$ 20 million commitment to the International Finance Facility for Immunisation (IFFIm) in 2006. During the COVID-19 pandemic, Brazil contributed US$ 86.7 million to support equitable access to vaccines through COVAX. In 2025, Brazil further strengthened its partnership with Gavi by contributing more than US$ 72 million in support of Gavi’s 2026–2030 strategic period (Gavi 6.0).
Beyond its financial contributions, Brazil is a strategic partner in vaccine supply and innovation: Brazil has championed regional manufacturing initiatives and global health cooperation, reinforcing its role as an important partner in advancing vaccine equity and health security worldwide.
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: